The company is using the cash to open an office in the Bay Area and compete for talent there, “strengthening its position at the heart of the world’s leading AI ecosystem.”
Related Posts
Why trust is a big question at the Elon Musk-OpenAI trial
A big theme in the trial’s final days was whether OpenAI CEO Sam Altman is trustworthy.
The US-China AI gap closed. The responsible AI gap didn’t
The assumption that the US holds a durable lead in AI model performance is not well-supported by the…
AI is spitting out more potential drugs than ever. This start-up wants to figure out which ones matter.
10x Science has raised a $4.8 million seed round to help pharmaceutical researchers understand complex molecules.